AU5612199A - Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other - Google Patents

Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other

Info

Publication number
AU5612199A
AU5612199A AU56121/99A AU5612199A AU5612199A AU 5612199 A AU5612199 A AU 5612199A AU 56121/99 A AU56121/99 A AU 56121/99A AU 5612199 A AU5612199 A AU 5612199A AU 5612199 A AU5612199 A AU 5612199A
Authority
AU
Australia
Prior art keywords
compositions
phytostanols
phytosterols
delta
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56121/99A
Inventor
David John Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Forbes Medi-Tech Inc
Original Assignee
Forbes Medi-Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forbes Medi-Tech Inc filed Critical Forbes Medi-Tech Inc
Publication of AU5612199A publication Critical patent/AU5612199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU56121/99A 1998-09-10 1999-09-10 Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other Abandoned AU5612199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15138598A 1998-09-10 1998-09-10
US09151385 1998-09-10
PCT/CA1999/000814 WO2000015201A2 (en) 1998-09-10 1999-09-10 Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other disorders

Publications (1)

Publication Number Publication Date
AU5612199A true AU5612199A (en) 2000-04-03

Family

ID=22538532

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56121/99A Abandoned AU5612199A (en) 1998-09-10 1999-09-10 Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other

Country Status (2)

Country Link
AU (1) AU5612199A (en)
WO (1) WO2000015201A2 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078296A2 (en) * 1999-06-17 2000-12-28 Basf Aktiengesellschaft Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
CA2403977C (en) * 2000-03-31 2009-09-01 Eisai Co., Ltd. .gamma.-tocotrienol-containing diuretics
IL152175A (en) 2000-04-14 2005-08-31 Mars Inc Compositions and methods for improving vascular health
GB0026018D0 (en) 2000-10-24 2000-12-13 Novartis Nutrition Ag New composition
PL1732605T3 (en) 2004-03-29 2019-09-30 Wyeth Llc Multi-vitamin and mineral nutritional supplements
WO2005099484A1 (en) * 2004-04-16 2005-10-27 Unilever N.V. Water continuous product comprising sterol or stanolester and a tocopherol
US7572805B2 (en) 2004-07-14 2009-08-11 Bristol-Myers Squibb Company Pyrrolo(oxo)isoquinolines as 5HT ligands
US7517991B2 (en) 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
US7314882B2 (en) 2005-01-12 2008-01-01 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US7368458B2 (en) 2005-01-12 2008-05-06 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
WO2006076569A2 (en) 2005-01-12 2006-07-20 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid receptor modulators
US20060160850A1 (en) 2005-01-18 2006-07-20 Chongqing Sun Bicyclic heterocycles as cannabinoid receptor modulators
EP1846410B1 (en) 2005-02-10 2009-01-21 Bristol-Myers Squibb Company Dihydroquinazolinones as 5ht modulators
US7317012B2 (en) 2005-06-17 2008-01-08 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoind-1 receptor modulators
US7629342B2 (en) 2005-06-17 2009-12-08 Bristol-Myers Squibb Company Azabicyclic heterocycles as cannabinoid receptor modulators
US7452892B2 (en) 2005-06-17 2008-11-18 Bristol-Myers Squibb Company Triazolopyrimidine cannabinoid receptor 1 antagonists
US7632837B2 (en) 2005-06-17 2009-12-15 Bristol-Myers Squibb Company Bicyclic heterocycles as cannabinoid-1 receptor modulators
US7572808B2 (en) 2005-06-17 2009-08-11 Bristol-Myers Squibb Company Triazolopyridine cannabinoid receptor 1 antagonists
US7795436B2 (en) 2005-08-24 2010-09-14 Bristol-Myers Squibb Company Substituted tricyclic heterocycles as serotonin receptor agonists and antagonists
AR056155A1 (en) 2005-10-26 2007-09-19 Bristol Myers Squibb Co ANTAGONISTS OF NON-BASIC MELANINE CONCENTRATION HORMONE RECEIVER 1
US7553836B2 (en) 2006-02-06 2009-06-30 Bristol-Myers Squibb Company Melanin concentrating hormone receptor-1 antagonists
MY162051A (en) 2007-05-24 2017-05-31 Loders Croklaan Bv Process for producing compositions comprising tocopherols and tocotrienols
US20090011994A1 (en) 2007-07-06 2009-01-08 Bristol-Myers Squibb Company Non-basic melanin concentrating hormone receptor-1 antagonists and methods
EP2042180A1 (en) * 2007-09-28 2009-04-01 Swiss Caps Rechte und Lizenzen AG Preparations containing phytosterol
PE20091928A1 (en) 2008-05-29 2009-12-31 Bristol Myers Squibb Co HAVE HYDROXYSUSTITUTED PYRIMIDINES AS NON-BASIC MELANIN-CONCENTRATING HORMONE RECEPTOR-1 ANTAGONISTS
MX2011009852A (en) 2009-03-27 2011-09-29 Bristol Myers Squibb Co Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors.
WO2014039412A1 (en) 2012-09-05 2014-03-13 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
US9586900B2 (en) 2012-09-05 2017-03-07 Bristol-Myers Squibb Company Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
SG11202100417RA (en) 2018-07-19 2021-02-25 Astrazeneca Ab Methods of treating hfpef employing dapagliflozin and compositions comprising the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
EP0962150B1 (en) * 1995-06-01 2003-08-13 Unilever N.V. Fat based food products
NZ280689A (en) * 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
TW360501B (en) * 1996-06-27 1999-06-11 Nestle Sa Dietetically balanced milk product
WO1998003084A1 (en) * 1996-07-18 1998-01-29 Nutricor, Inc. Nutritious food preparations and methods for making them
JP2001512312A (en) * 1997-02-12 2001-08-21 コブラ セラピューティクス リミテッド Compositions and methods for high efficiency transfection
US6126943A (en) * 1997-09-02 2000-10-03 The Ricex Company Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis

Also Published As

Publication number Publication date
WO2000015201A2 (en) 2000-03-23
WO2000015201A3 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU5612199A (en) Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
HUP0302881A3 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP9900413A3 (en) Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives
IL135176A0 (en) Benzothiazole derivatives and pharmaceutical compositions containing the same
HUP0103575A3 (en) Inhibitors of caspases, pharmaceutical compositions comprising thereof and their use
IL133613A0 (en) Epothilone derivatives and pharmaceutical compositions containing same
HUP0200155A2 (en) Thioamide derivatives, pharmaceutical compositions containing them and their use
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
EP1076547A4 (en) Derivatives of arabinogalactan and compositions including the same
IL157908A0 (en) Phthalazinone derivatives and pharmaceutical compositions containing the same
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL145012A0 (en) Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
IL141080A0 (en) Disubstituted maleimide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase